{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:23:04Z","timestamp":1791256984564,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue d'\u00c9pid\u00e9miologie et de Sant\u00e9 Publique"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.respe.2015.12.017","type":"journal-article","created":{"date-parts":[[2016,3,10]],"date-time":"2016-03-10T10:00:48Z","timestamp":1457604048000},"page":"103-112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Cancer incidence in France over the 1980\u20132012 period: Hematological malignancies"],"prefix":"10.1016","volume":"64","author":[{"given":"S.","family":"Le Guyader-Peyrou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Belot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Maynadi\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Binder-Foucard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Remontet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Troussard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Bossard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Monnereau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.respe.2015.12.017_bib0185","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.respe.2015.12.017_bib0190","series-title":"Estimation nationale de l\u2019incidence et de la mortalit\u00e9 par cancer en France entre 1980 et 2005","author":"Belot","year":"2008"},{"key":"10.1016\/j.respe.2015.12.017_bib0195","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.respe.2008.03.117","article-title":"Cancer incidence and mortality in France over the period 1980\u20132005","volume":"56","author":"Belot","year":"2008","journal-title":"Rev Epidemiol Sante Publique"},{"key":"10.1016\/j.respe.2015.12.017_bib0200","series-title":"Plan cancer 2009\u20132013","year":"2010"},{"issue":"2","key":"10.1016\/j.respe.2015.12.017_bib0205","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.respe.2013.11.073","article-title":"Cancer incidence and mortality in France over the 1980\u20132012 period: solid tumors","volume":"62","author":"Binder-Foucard","year":"2014","journal-title":"Rev Epidemiol Sante Publique"},{"key":"10.1016\/j.respe.2015.12.017_bib0210","series-title":"International classification of diseases for oncology","author":"Fritz","year":"2000"},{"key":"10.1016\/j.respe.2015.12.017_bib0215","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow","year":"2008"},{"issue":"2","key":"10.1016\/j.respe.2015.12.017_bib0220","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1182\/blood-2006-11-051672","article-title":"Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph)","volume":"110","author":"Morton","year":"2007","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.respe.2015.12.017_bib0225","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1182\/blood-2010-06-289561","article-title":"InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions","volume":"116","author":"Turner","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.respe.2015.12.017_bib0230","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group","volume":"84","author":"Harris","year":"1994","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.respe.2015.12.017_bib0235","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0398-7620(05)84589-4","article-title":"Age in completed years versus age reached during the year","volume":"53","author":"Hill","year":"2005","journal-title":"Rev Epidemiol Sante Publique"},{"key":"10.1016\/j.respe.2015.12.017_bib0240","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/ije\/29.5.878","article-title":"Analysing the difference due to risk and demographic factors for incidence or mortality","volume":"29","author":"Bashir","year":"2000","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.respe.2015.12.017_bib0250","series-title":"Estimation nationale de l\u2019incidence des cancers en France entre 1980 et 2012. Partie 2\u00a0\u2013\u00a0H\u00e9mopathies malignes","author":"Monnereau","year":"2013"},{"key":"10.1016\/j.respe.2015.12.017_bib0255","series-title":"SEER Cancer Statistics Review, 1975\u20132010","author":"Howlader","year":"2012"},{"issue":"19","key":"10.1016\/j.respe.2015.12.017_bib0260","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.1182\/blood-2010-05-282632","article-title":"Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project","volume":"116","author":"Sant","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.respe.2015.12.017_bib0265","series-title":"Caract\u00e9ristiques \u00e9pid\u00e9miologiques des h\u00e9mopathies lympho\u00efdes en France en 2006-2008","author":"Maynadi\u00e9","year":"2013"},{"issue":"11","key":"10.1016\/j.respe.2015.12.017_bib0270","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1038\/bjc.2011.450","article-title":"Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network","volume":"105","author":"Smith","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1016\/j.respe.2015.12.017_bib0275","series-title":"NORDCAN: Cancer Incidence, Mortality, Prevalence and Survival in the Nordic Countries, Version 5. 3","author":"Engholm","year":"2013"},{"issue":"25","key":"10.1016\/j.respe.2015.12.017_bib0280","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.1182\/blood-2010-07-298760","article-title":"Racial disparities in incidence and outcome in multiple myeloma: a population-based study","volume":"116","author":"Waxman","year":"2010","journal-title":"Blood"},{"issue":"17","key":"10.1016\/j.respe.2015.12.017_bib0285","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1016\/j.ejca.2012.05.024","article-title":"Incidence, survival and prevalence of myeloid malignancies in Europe","volume":"48","author":"Visser","year":"2012","journal-title":"Eur J Cancer"},{"issue":"12","key":"10.1016\/j.respe.2015.12.017_bib0290","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1023\/A:1008375931236","article-title":"The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997","volume":"10","author":"Harris","year":"1999","journal-title":"Ann Oncol"},{"issue":"15","key":"10.1016\/j.respe.2015.12.017_bib0295","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1182\/blood-2012-08-448068","article-title":"Evolving risk of therapy-related acute myeloid leukemia following cancer chemotherapy among adults in the United States, 1975\u20132008","volume":"121","author":"Morton","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.respe.2015.12.017_bib0300","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1365-2559.2010.03696.x","article-title":"Epidemiology of lymphomas","volume":"58","author":"Roman","year":"2011","journal-title":"Histopathology"},{"issue":"48","key":"10.1016\/j.respe.2015.12.017_bib0305","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/jncimonographs\/lgu013","article-title":"Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph Non-Hodgkin Lymphoma Subtypes Project","volume":"2014","author":"Morton","year":"2014","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"Suppl.\u00a012","key":"10.1016\/j.respe.2015.12.017_bib0310","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/ijc.22718","article-title":"Multiple myeloma: a review of the epidemiologic literature","volume":"120","author":"Alexander","year":"2007","journal-title":"Int J Cancer"},{"issue":"8","key":"10.1016\/j.respe.2015.12.017_bib0315","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1182\/blood-2008-05-159665","article-title":"Relationship between monoclonal gammopathy of undetermined significance and radiation exposure in Nagasaki atomic bomb survivors","volume":"113","author":"Iwanaga","year":"2009","journal-title":"Blood"},{"issue":"25","key":"10.1016\/j.respe.2015.12.017_bib0320","doi-asserted-by":"crossref","first-page":"6386","DOI":"10.1182\/blood-2009-02-203471","article-title":"Pesticide exposure and risk of monoclonal gammopathy of undetermined significance in the Agricultural Health Study","volume":"113","author":"Landgren","year":"2009","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.respe.2015.12.017_bib0325","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1365-2141.2011.08798.x","article-title":"Genetic variation at the 8q24 locus confers risk to multiple myeloma","volume":"156","author":"Tewari","year":"2012","journal-title":"Br J Haematol"},{"issue":"9278","key":"10.1016\/j.respe.2015.12.017_bib0330","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0140-6736(01)05498-8","article-title":"Incidence of Hodgkin's disease in Nordic countries","volume":"358","author":"Hjalgrim","year":"2001","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.respe.2015.12.017_bib0335","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/ijc.23504","article-title":"Changing patterns of Hodgkin lymphoma incidence in Singapore","volume":"123","author":"Hjalgrim","year":"2008","journal-title":"Int J Cancer"},{"issue":"7","key":"10.1016\/j.respe.2015.12.017_bib0340","first-page":"B4485","article-title":"On the aetiology of Hodgkin lymphoma","volume":"59","author":"Hjalgrim","year":"2012","journal-title":"Dan Med J"},{"issue":"10","key":"10.1016\/j.respe.2015.12.017_bib0345","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1002\/ijc.27889","article-title":"Unbiased estimates of long-term net survival of hematological malignancy patients detailed by major subtypes in France","volume":"132","author":"Monnereau","year":"2013","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.respe.2015.12.017_bib0350","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1053\/j.semdp.2011.02.001","article-title":"Lymphoma classification: the quiet after the storm","volume":"28","author":"Pileri","year":"2011","journal-title":"Semin Diagn Pathol"},{"issue":"1","key":"10.1016\/j.respe.2015.12.017_bib0355","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1158\/1055-9965.EPI-03-0250","article-title":"Expert review of non-Hodgkin's lymphomas in a population-based cancer registry: reliability of diagnosis and subtype classifications","volume":"13","author":"Clarke","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"8","key":"10.1016\/j.respe.2015.12.017_bib0360","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.3109\/10428194.2013.774000","article-title":"Dissecting lymphoma incidence to inform epidemiologic and clinical research","volume":"54","author":"Morton","year":"2013","journal-title":"Leuk Lymphoma"}],"container-title":["Revue d'\u00c9pid\u00e9miologie et de Sant\u00e9 Publique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0398762016001206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0398762016001206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:37:59Z","timestamp":1759970279000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0398762016001206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S0398762016001206"],"URL":"https:\/\/doi.org\/10.1016\/j.respe.2015.12.017","relation":{},"ISSN":["0398-7620"],"issn-type":[{"value":"0398-7620","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer incidence in France over the 1980\u20132012 period: Hematological malignancies","name":"articletitle","label":"Article Title"},{"value":"Revue d'\u00c9pid\u00e9miologie et de Sant\u00e9 Publique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.respe.2015.12.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}